PNA oligomers as tools for specific modulation of gene expression

被引:65
作者
Pooga, M
Land, T
Bartfai, T
Langel, Ü
机构
[1] Estonian Bioctr, EE-51010 Tartu, Estonia
[2] Stockholm Univ, Arrhenius Lab, Dept Neurochem & Neurotoxicol, S-10691 Stockholm, Sweden
[3] Scripps Res Inst, Dept Neuropharmacol, Harold L Dorris Neurol Res Ctr, La Jolla, CA 92037 USA
来源
BIOMOLECULAR ENGINEERING | 2001年 / 17卷 / 06期
关键词
antigene; antisense; PNA; PNA delivery;
D O I
10.1016/S1389-0344(01)00075-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Small synthetic molecules that can specifically inhibit translation and/or transcription have shown great promise as potential antisense/antigene drugs. Peptide nucleic acid (PNA), an oligonucleotide mimic, has a non-charged achiral polyamide backbone to which the nucleobases are attached. PNA oligomers are extremely stable in biological fluids and they specifically hybridise to DNA or RNA in a complementary manner, forming very strong heteroduplexes. Some of the mRNAs have yet undetermined and possibly long half-lives, successful down regulation of gene expression by antisense oligonucleotides (ON) requires that the antisense agent is long lived. PNA fulfils this requirement better than phosphodiester or phsphorothioate ONs. PNA can inhibit transcription and translation of respective genes by tight binding to DNA or mRNA. First in vitro experiments to specifically down regulate protein expression by PNA have been followed by successful antisense and antigene application of PNA oligomers in vivo. This review discusses the principles of the in vitro and in vivo use of PNA oligonucleotides. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 192
页数:10
相关论文
共 68 条
[1]   A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide.: The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons [J].
Aldrian-Herrada, G ;
Desarménien, MG ;
Orcel, H ;
Boissin-Agasse, L ;
Méry, J ;
Brugidou, J ;
Rabié, A .
NUCLEIC ACIDS RESEARCH, 1998, 26 (21) :4910-4916
[2]   Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates [J].
Astriab-Fisher, A ;
Sergueev, DS ;
Fisher, M ;
Shaw, BR ;
Juliano, RL .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (01) :83-90
[3]   Inhibition of a DNA-helicase by peptide nucleic acids [J].
Bastide, L ;
Boehmer, PE ;
Villani, G ;
Lebleu, B .
NUCLEIC ACIDS RESEARCH, 1999, 27 (02) :551-554
[4]   Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake [J].
Basu, S ;
Wickstrom, E .
BIOCONJUGATE CHEMISTRY, 1997, 8 (04) :481-488
[5]   Enhanced peptide nucleic acid binding to supercoiled DNA: Possible implications for DNA ''breathing'' dynamics [J].
Bentin, T ;
Nielsen, PE .
BIOCHEMISTRY, 1996, 35 (27) :8863-8869
[6]   A NUCLEIC-ACID TRIPLE-HELIX FORMED BY A PEPTIDE NUCLEIC-ACID DNA COMPLEX [J].
BETTS, L ;
JOSEY, JA ;
VEAL, JM ;
JORDAN, SR .
SCIENCE, 1995, 270 (5243) :1838-1841
[7]  
Boffa LC, 2000, CANCER RES, V60, P2258
[8]   ISOLATION OF ACTIVE GENES CONTAINING CAG REPEATS BY DNA STRAND INVASION BY A PEPTIDE NUCLEIC-ACID [J].
BOFFA, LC ;
CARPANETO, EM ;
ALLFREY, VG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :1901-1905
[9]   AN ASSESSMENT OF THE ANTISENSE PROPERTIES OF RNASE H-COMPETENT AND STERIC-BLOCKING OLIGOMERS [J].
BONHAM, MA ;
BROWN, S ;
BOYD, AL ;
BROWN, PH ;
BRUCKENSTEIN, DA ;
HANVEY, JC ;
THOMSON, SA ;
PIPE, A ;
HASSMAN, F ;
BISI, JE ;
FROEHLER, BC ;
MATTEUCCI, MD ;
WAGNER, RW ;
NOBLE, SA ;
BABISS, LE .
NUCLEIC ACIDS RESEARCH, 1995, 23 (07) :1197-1203
[10]   A peptide nucleic acid-nuclear localization signal fusion that mediates nuclear transport of DNA [J].
Brandén, LJ ;
Mohamed, AJ ;
Smith, CIE .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :784-787